![Lilly’s Antibody Clinical Trial in Nursing Homes Prevents COVID](https://www.uplifthc.com/wp-content/uploads/2021/01/pexels-anna-shvets-5231283.jpg)
Lilly’s Antibody Clinical Trial in Nursing Homes Prevents COVID
A Phase 3 clinical trial of an antibody-drug that enrolled residents and staff at skilled nursing and assisted living facilities found that the treatment significantly reduced the risk of contracting symptomatic COVID-19.